当前位置: 首页 > 期刊 > 《中外医学研究》 > 2017年第32期
编号:13214308
正清风痛宁联合甲氨蝶呤在类风湿关节炎患者中辅助治疗效果及对实验室指标影响(3)
http://www.100md.com 2017年11月15日 中外医学研究 2017年第32期
     [5] Aslibekyan S,Brown E E,Reynolds R J,et al.Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis:results from the treatment of early aggressive rheumatoid arthritis trial[J].The Pharmacogenomics Journal,2014,14(1):48-53.

    [6]李兆福,刘维超,彭江云,等.蠲痹颗粒联合甲氨蝶呤片治疗活动性类风湿关节炎140例临床观察[J].中医杂志,2014,55(18):1566-1570.

    [7]李兆福,彭江云,杨会军,等.蠲痹颗粒治疗寒湿痹阻型类风湿关节炎60例临床观察[J].中国中医药科技,2014,21(3):291-292,300.

    [8] Sakai T,Tamura S,Miyoshi T,et al.Development of myeloid sarcoma after long-term methotrexate use for rheumatoid arthritis[J].International Journal of Hematology,2014,99(4):493-498.

    [9] Cipriani P,Ruscitti P,Carubbi F,et al.Methotrexate in rheumatoid arthritis: Optimizing therapy among different formulations. Current and emerging paradigms[J].Clinical Therapeutics,2014,36(3):427-435.

    [10]安香珍,杨红霞,邢燕军,等.五联疗法对类风湿关节炎患者血清IL-37、IFN-γ、CD-62p、CD-41水平的影响[J].現代中西医结合杂志,2016,25(28):3095-3097.

    [11] Dhir V,Singla M,Gupta N,et al.Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis[J].Clinical Therapeutics,2014,36(7):1005-1015.

    [12]安香珍,杨红霞,邢燕军,等.中西医结合治疗类风湿关节炎疗效及对患者血清TNF-α及BAP水平的影响[J].现代中西医结合杂志,2016,25(22):2431-2433.

    (收稿日期:2017-09-20), 百拇医药(张亚兵 赵荣)
上一页1 2 3